J. Jpn. Oil Chem. Soc. Vol.48, No.1 (1999) 37

Synthesis of Episterol, 5-Dehydroepisterol and Their Deuterio-labeled Analogs

Suguru TAKATSUTO*1, Chiharu GOTOH*1, Takahiro NOGUCHI*2, and Shozo FUJIOKA*3

*1 Department of Chemistry, Joetsu Universiry of Education (1, Yamayashiki-machi, Joetsu-shi,Niigata-ken 943-8512) *2 Tama Biochemical Co. Ltd. (2-7-1,Nishishinjuku Shinjuku-ku, Tokyo 163-0704) *3 The Instituteof Paysical and Chemical Research (RIKEN) (2-1, Hirosawa, Wako-shi, Saitama-ken 351-0198)

Abstract: To identify and conduct metabolic studies on in Arabidopsis dwarf mutants, episterol, 5-dehydroepisterol, [26, 27-2H6] 5-dehydroepisterol and [26, 27-2H6] episterol were synthesized from 3 ƒÀ-acetoxycholest-5-en-24-one or its deuteno-labeled analog by introduction of the 5, 7-diene group, olefination of the 24-oxo group with Tebbe reagent and reduction of 5, 7-diene with sodium as key reactions. Key words: synthesis, 5-dehydroepisterol, episterol, [26, 27-2H6] 5-dehydroepisterol, [26, 27-2H6] episterol

1 Introduction The authors recently established an outline for the of phytohormones or brassinoster- oids from a common , campesterol 11). During a study on dwarf mutants of Arabidopsis Campesterol 1 24-Methylenecholesterol 2 thaliana L., whose phenotypes were rescued by exogenous application of brassinosteroids, two novel dwarf mutants, dwf 5 and dwf 7, were found to be defective in brassinosteroid biosynthesis and both of them were blocked before 24-methyl- enecholesterol 2 in biosynthesis, based on 5-Dehydroepisterol 3 Episterol 4 the results of a feeding experiment with biosynthe- Fig. 1 Structures of Campesterol and Related C28 tic intermediates and particularly the quantitative Sterols. analysis of endogenous sterols and brassi- nosteroids2). To clarify blocked steps in the reported by Fryberg et al.8) and requires long biosynthetic pathway, attention was initially reaction steps for both sterols. The authors thus directed to 5-dehydroepisterol 3 and episterol 4 endeavored to develop a short-step synthesis of 5- (Fig. 1), situated just before 24-methylene- dehydroepisterol 3 and episterol 4 for the identi- 2 in the sterol biosynthetic pathway3),4). fication and the metabolic study of the deuterio- 5-Dehydroepisterol 3 and episterol 4 were labeled analogs. previously isolated from yeast5) and Mucor rouxii6) and this work proved to be a tedious and time- consuming. Sterols 3 and 4 are not commonly 2 Experimental found in plants7) and, thus, are not readily 2•E1 Analytical Methods available from natural sources. The synthesis of 5- Melting points were determined under a hot- dehydroepisterol 3 and episterol 4 was previously stage microscope (Yanagimoto micro melting

point apparatus) and not corrected. 1H-NMR spectra were recorded on a JEOL JMN-A 400 (400 Corresponding author: Suguru TAKATSUTO MHz) or JEOL JMN-ECP 500 (500MHz)

37 38 J. Jpn. Oil Chem. Soc. Vol.48, No.1 (1999)

spectrometer in a deuterio-chloroform (CDCl3) was treated with 5% KOH/methanol (MeOH) (3

solution using tetramethylsilane as the internal mL) at room temperature in the dark under argon

standard. EI-MS and HR-EI-MS were measured for 2h. The work-up (EtOAc) gave a crude

with a JEOL SX-102 mass spectrometer at 70eV. product, which was then applied onto eight plates GC-MS was conducted with a Shimadzu GC-MS of silica gel (20cm x 20cm, 0.5mm thickness,

QP-5000 spectrometer equipped with a ULBON Kieselgel 60F254, Merck). The plates were de-

HR-1 fused silica capillary column, as described veloped with benzene-EtOAc (10:1, vol/vol). The

previously9). silica gel band with RF 0.31•`0.36 was scraped off,

2•E2 Synthesis eluted with EtOAc, filtered and concentrated

2•E2•E1 Preparation of 3 ƒÀ3-hydroxycholesta-5, 7- below 30•Ž to afford 3 ƒÀ-hydroxycholesta-5, 7-

dien-24-one 7. dien-24-one 7 (71mg, 47%), mp 61•`62•Ž (from

A solution of a known 3 ƒÀ-acetoxycholest-5-en- McOH), 1H-NMR (CDCl3, 500MHz) ƒÂ: 0.618 (3

24-one 510) (167mg, 0.378mmol) in carbon H, s, 18-H3), 0.941 (3H, d, J=6.56Hz, 21-H3), tetrachloride (9mL) was treated with N-bromo- 0.943 (3H, s, 19-H3), 1.095 (6H, d x 2, J=7.05Hz, succinimide (79mg, 0.444mmol) at 100•Ž under 26-H3 and 27-H3), 2.614 (1H, sept, J=7.05Hz,

argon for 20min. The reaction mixture was cooled 25-H), 3.640 (1H, m, 3ƒ¿-H), 5.392 (1H, dt, J= to 0•Ž; the precipitate was filtered off and filtrate 5.59 and 2.80Hz, 6-H), 5.576 (1H, dd, J=5.71 concentrated below 30•Ž to give a mixture of and 2.31Hz, 7-H). EI-MS m/z (rel. int.): 398 (M+, corresponding 7-bromides 6. The bromide in 75), 380 (42), 365 (100), 339 (39), 253 (54), 251 tetrahydrofuran (THF) (12mL) was treated with (35), 211 (31). HR-EI-MS; Calcd. for C27H42O2 tetra-n-butylammonium bromide (15mg) at room (M+): 398.3187, Found: 398.3179. temperature in the dark under argon for 1h. A 2•E2•E2 Preparation of ergosta-5, 7, 24 (28)-trien- solution of tetra-n-butylammonium fluoride in 3 ƒÀ-ol, 5-dehydroepisterol 3

THF (1M, 1.5mL) was then added to the system A solution of 3 ƒÀ-hydroxycholesta-5, 7-dien-24- followed by additional stirring in the dark at room one 7 (61.0mg, 0.153mmol) in THF (6mL) was temperature under argon for 30min. The work-up treated with Tebbe reagent11) (0.5M, 0.6mL,

(ethyl acetate, EtOAc) gave a crude 3 ƒÀ-acetoxy- Aldrich) at 0•Ž under argon for 40min. The work- cholesta-5, 7-dien-24-one, which in THF (9mL) up (diethyl ether) gave a crude product which was

Scheme 1 Reagents and conditions: i, N-bromosuccinimide , CCl4, reflux, 20min; ii, (n- Bu)4NBr/THF, room temp., 1h; iii, (n-Bu)4NF/THF , room temp., 30min; iv, 5% KOH/MeOH, room temp., 2h; v, Tebbe reagent/THF , 0•Ž, 40min; vi, Na/t-BuOH-THF, 45•Ž, 2h.

38 J. Jpn. Oil Chem. Soc. Vol.48, No.1 (1999) 39

applied onto four plates of silica gel (20cm x 20 205nm], episterol 4 (1.1mg) was isolated from cm, 0.5mm thickness). The plates were developed one-half the mixture: mp 125•`127•Ž (from twice with hexane-EtOAc (5:1, vol/vol). The McOH) (lit.5), mp 125•`126•Ž), 1H-NMR (CDCl3,

silica gel band with RF 0.26•`0.33 was scraped off 400MHz) ƒÂ: 0.539 (3H, s, 18-H3), 0.797 (3H, s, and eluted with EtOAc. Filtration and removal of 19-H3), 0.955 (3H, d, J=6.83Hz, 21-H3), 1.023

the solvent in vacuo gave 5-dehydroepisterol 3 (28 (3H, d, J=6.83Hz, 26-H3), 1.029 (3H, d, J=6.83 mg, 46%), mp 118•`120•Ž (from McOH) (lit.8), Hz, 27-H3), 2.230 (1H, sept, J=6.83Hz, 25-H),

mp 129•`130.5•Ž), 1H-NMR (CDCl3, 500MHz) ƒÂ 3.596 (1H, m, 3 ƒ¿-H), 4.658 (1H, d, J=0.98Hz, : 0.620(3H, s, 18-H3),0.941 (3H, s, 19-H3),0.970 28-H), 4.714 (1H, s, 28-H), 5.162 (1H, dd, J=

(3H, d, J=6.60Hz, 21-H3), 1.021 (3H, d, J=6.86 4.88 and 2.43Hz, 7-H). EI-MS m/z (rel. int.): 398

Hz, 26-H3), 1.026 (3H, d, J=6.86Hz, 27-H3), (M+, 22), 383 (26), 380 (8), 365 (9), 314 (42), 299 2.229 (1H, sept, J=6.86Hz, 25-H), 3.635 (1H, (13), 271 (100), 269 (25), 255 (20), 253 (16), 231 m, 3 ƒ¿-H), 4.657 (1H, d, J=0.98Hz, 28-H), 4.715 (14), 213 (19). HR-EI-MS; Calcd. for C28H46O

(1H, s, 28-H), 5.386 (1H, dt, J=5.84 and 2.43 (M+): 398.3551, Found: 398.3549. Hz, 6-H), 5.571 (1H, dd, J=5.46 and 2.41Hz, 7- 2•E2•E5 Preparation of [26, 27-2H6] 5 ƒ¿-ergosta-

H). EI-MS m/z (rel. int.): 396 (97), 381 (11), 378 7, 24 (28)-lien-3 ƒÀ-ol, [26, 27-2H6] episterol 10

(15), 363 (100), 349 (9), 337 (73), 323 (6), 253 (24), As described above, [26, 27-2H6] 5-dehydroepis- 251 (18), 211 (36). HR-EI-MS; Calcd. for C28H44O terol 9 (4.5mg) was converted to [26, 27-2H6]

(M+): 396.3394, Found: 396.3395. episterol 10 (1.68mg), mp 126•`129•Ž (from 2•E2• 3 Preparation of [26, 27-2H6] ergosta- McOH-chloroform), 1H-NMR (CDCl3, 400MHz)

5, 7, 24 (28)-trien-3 ƒÀ-ol, [26, 27-2H6] 5-dehydroepis- δ: 0.541 (3H, s, 18-H3), 0.797 (3H, s, 19-H3),

terol 9 0.955 (3H, d, J=6.83Hz, 21-H3), 2.191 (1H, br s,

As described above, [25, 26, 27-2H7] 3 ƒÀ-ace- 25-H), 3.590 (1H, m, 3 ƒ¿-H), 4.656 (1H, d, J=

toxycholest-5-en-24-one 8 (37mg), derived from a 0.97Hz, 28-H), 4.707 (1H, s, 28-H), 5.162 (1H,

known [25, 26, 27-2H7] 3 ƒÀ-tetrahydropyrany- dd, J=4.88 and 2.44Hz, 7-H). EI-MS m/z (rel.

loxycholest-5-en-24-one9), was converted to [26, 27- int.): 404 (M+, 27), 389 (23), 386 (21), 371 (14), 2H 6] 5-dehydroepisterol 9 (7.5mg), mp 119~ 314 (51), 299 (11), 296 (17), 271 (100), 255 (21),

122℃ (from McOH), 1H-NMR (CDCl3, 400MHz) 253 (37), 231 (11), 213 (18). HR-EI-MS; Calcd.

δ: 0.627 (3H, s, 18-H3), 0.947 (3H, s, 19-H3), for C28H40OD6 (M+): 404.3927, Found: 404.3931.

0.977 (3H, d, J=6.83Hz, 21-H3), 2.195 (1H, br s,

25-H), 3.641 (1H, m, 3 ƒ¿-H), 4.661 (1H, d, J= 3 Results and Discussion 1.46Hz, 28-H), 4.713 (1H, s, 28-H), 5.392 (1H,

dt, J=5.86 and 2.44Hz, 6-H), 5.576 (1H, dd, J= Synthesis of 5-dehydroepisterol 3 and episterol 4

5.37 and 2.44Hz, 7-H). EI-MS m/z (rel, int.): 402 was initiated from a known 3 ƒÀ-acetoxycholest-5-

(M+, 85), 387 (5), 384 (60), 369 (100), 343 (34), en-24-one 510). By the method used for vitamin D12), 253 (71), 251 (26), 211 (23). HR-EI-MS; Calcd. a 5, 7-diene function was introduced as follows. for C28H38OD6 (M+): 402.3770, Found: 402.3781. 5 was brominated at the C-7 position with

2•E2•E4 Preparation of 5 ƒ¿-ergosta-7, 24 (28)- N-bromosuccinimide. The ratio of the resulting dien-3 ƒÀ-ol, episterol 4 7 ƒ¿- to 7 ƒÀ-bromides 6 increased by treatment with

A solution of 5-dehydroepisterol 3 (14.0mg, tetra-n-butylammonium bromide. The 7ƒ¿-bro-

35.4ƒÊmol) in t-butanol (1mL) and THE (2mL) mide enriched mixture 6 was dehydrobrominated was treated with sodium (five tips) at 45•Ž under with tetra-n-butylammonium fluoride to afford, argon for 2h. The work-up (diethyl ether) gave a subsequent to saponification, 3ƒÀ-hydroxycholesta- product (14mg), a small portion of which was 5, 7-lien-24-one 7 in 47% yield from 5. analyzed by GC-MS after trimethylsilylation, thus As reported for deuterio-labeled 24- showing the product to consist of desired episterol methylenecholesterol and its related steroids9), the

4 (24%) and starting material 3 (76%). By olefination of 3 ƒÀ-hydroxycholesta-5, 7-lien-24-one preparative HPLC [column, Senshu Pak ODS 7 was carried out with Tebbe reagent11) and 5- 4150-N (15cm x 1.0cm i.d.); mobile phase, dehydroepisterol 3 was obtained in 46% yield.

McOH; flow rate, 2mL• min-1; detection, UV Reduction of the 5, 7-diene group of 3 with sodium

39 40 J. Jpn. Oil Chem. Soc. Vol.48, No.1 (1999)

metah13) gave a mixture of 5-dehydroepisterol 3 Acknowledgement (76%) and episterol 4 (24%), from which episterol 4 was isolated by preparative HPLC. The authors thank Mr. Robert A. Hargis for

Overall yields of 5-dehydroepisterol 3 and editing the manuscript. episterol 4 from 3 ƒÀ-acetoxycholest-5-en-24-one 5 (Received Aug. 20, 1998; Accepted Sept. 24, 1998) were low, compared to those obtained by Fryberg

et al8). The present synthesis has the following References merits: 1) milder and more rapid reaction conditions for dehydrobromination and olefination 1) A. Sakurai, S. Fujioka, Biosci. Biotech. Biochem. of 24-oxo group, 2) five-step reactions for the (review), 61, 757 (1997). 2) T. Noguchi, S. Fujioka, S. Takatsuto, S. Choe, preparation of 5-dehydroepisterol 3 from 3 ƒÀ- C.P. Tissier, A.S. Ross, K.A. Feldmann, S. acetoxycholest-5-en-24-one 5 (nine steps from the Yoshida, •gAbstract of The 16th International same intermediate 5 including exchange of protec- Conference on Plant Growth Substances tion groups) and 3) one step preparation of (IPGSA),•h 1998, August 13 to 17, Chiba, Japan, episterol 4 from 5-dehydroepisterol 3 (multi-step pp. 151. preparation from in their synthesis). 3) P. Benveniste, Ann. Rev. Plant Physiol., 37, 275 For the preparation of deuterio-labeled 5-de- (1986). hydroepisterol and episterol, [25, 26, 27-2H7] 3 ƒÀ- 4) W.D. Nes, M. Venkatramesh, •gBiochemistry and acetoxycholesta-5, 7-lien-24-one 8, derived from a Function of Sterols•h, ed. by E.J. Parish, W.D. Nes, known [25, 26, 27-2H7] 3 ƒÀ-tetrahydropyranyloxy- CRC Press, Inc., Champaign, New York (1997) p. cholesta-5, 7-dien-24-one9), was subjected to the 111. above reaction steps, since a deuterium atom at 5) D.H.R. Barton, U.M. Kempe, D.A. Widdowson, J. Chem. Soc., Perkin Trans. I, 513 (1972). the C-25 position was previously noted to be not 6) S. Safe, Biochim. Biophys. Acta, 326, 471 (1973). lost during olefination of 24-oxo group with Tebbe 7) T. Akihisa, W.C.M.C. Kokke, T. Matsumoto, reagent9). In the present study, the deuterium atom “Ph ysiology and Biochemistry of Sterols•h, ed. by at the C-25 position was completely lost possibly as G.W. Patterson, W.D. Nes, American Oil Chem- a result of enolization during saponification. The ists' Society, Champaign, Illinois (1991) p. 172. products were [26, 27-2H6] 5-dehydroepisterol 9 8) M. Fryberg, A.C. Oehlschlager, A.M. Unrau, and [26, 27-2H6] episterol 10, whose d6-content was J. Am. Chem. Soc., 95, 5747 (1973). found to be 98.5% by EI-MS. Nevertheless, as 9) S. Takatsuto, C. Gotoh, T. Noguchi, T. Nomura, substrates in feeding experiment, d6-sterols are S. Fujioka, T. Yokota, J. Chem. Res. (S), 206 sufficient for studying the biotransformation of (1998). episterol•¨5-dehydroepisterol•¨24-methyl- 10) Y.M. Sheikh, C. Djerassi, Tetrahedron, 30, 4095 enecholesterol in wild type and mutants of (1974). 11) F.N. Tebbe, G.W. Parshall, G.S. Reddy, J. Am. Arabidopsis. Chem. Soc., 100, 3611 (1978). The authors synthesized 5-dehydroepisterol 3, 12) T. Eguchi, H. Sai, S. Takatsuto, N. Hara, N. episterol 4, [26, 27-2H6] 5-dehydroepisterol 9 and Ikekawa, Chem. Pharm. Bull., 36, 2303 (1988). [26, 27-2H6] episterol 10. Clarification of the 13) D.H.R. Barton, X. Lusinchi, L. Magdzinski, J.S. blocked biosynthetic steps of the Arabidopsis Ramirez, J. Chem. Soc., Chem.Commun., 1236 dwarf mutants, dwf 5 and dwf 7, is presently in (1984). progress and the results will appear in a separate publication.

40 日本 油 化 学 会 誌 第48巻 第1号 (1999) 57

[ノー ト] Episterol, 5-dehydroepisterolお よ び そ れ ら の 重 水 素 標 識 体 の 合 成

高 津 戸 秀 *1・ 後 藤 千 春 *1・ 野 口 貴 弘 *2・ 藤 岡 昭 三 *3 *1 上 越 教 育 大 学 自 然 系 化 学 教 室(〒943-8512新 潟 県 上 越 市 山 屋 敷 町1) *2 タ マ 生 化 学(株)(〒163-0704東 京 都 新 宿 区 西 新 宿2-7-1)

*3 理 化 学 研 究 所 植 物 機 能 研 究 室(〒351-0198埼 玉 県 和 光 市 広 沢2-1)

シ ロ イ ヌ ナ ズ ナ の 倭 性 ミ ュ ー タ ン トに お け る 内 生 ス テ ロ ー ル の 同 定 お よ び 代 謝 研 究 用 にepisterol, 5-dehy- droepisterolお よ び そ れ ら の 重 水 素 標 識 体[26, 27-2H6] 5-dehydroepisterol, [26, 27-2H6] episterolを3β -acetoxycholest-5-en-24-oneま た は そ の 重 水 素 標 識 体 か ら ,5, 7-ジ エ ン の 導 入,24-oxo基 のTebbe試 薬 に よ

る オ レ フ ィ ン化 お よ び5, 7-ジ エ ン の ナ ト リ ウ ム に よ る 還 元 を 鍵 反 応 に 用 い て 合 成 し た 。 (連 絡 者:高 津 戸 秀) Vol.48, No.1, 37 (1999)

57